THIS PAGE IS UNDER CONSTRUCTION
1: Bilo L, Meo R. Polycystic ovary syndrome in women using valproate: a review.
Gynecol Endocrinol. 2008 Oct;24(10):562-70. doi: 10.1080/09513590802288259.
Review. PubMed PMID: 19012099.
2: McIntyre RS, Mancini DA, McCann S, Srinivasan J, Kennedy SH. Valproate,
bipolar disorder and polycystic ovarian syndrome. Bipolar Disord. 2003
Feb;5(1):28-35. PubMed PMID: 12656935.
3: Herzog AG, Schachter SC. Valproate and the polycystic ovarian syndrome: final
thoughts. Epilepsia. 2001 Mar;42(3):311-5. PubMed PMID: 11442145.
4: Genton P, Bauer J, Duncan S, Taylor AE, Balen AH, Eberle A, Pedersen B,
Salas-Puig X, Sauer MV. On the association between valproate and polycystic ovary
syndrome. Epilepsia. 2001 Mar;42(3):295-304. Review. PubMed PMID: 11442143.
5: Isojärvi JI, Taubøll E, Tapanainen JS, Pakarinen AJ, Laatikainen TJ, Knip M,
Myllylä VV. On the association between valproate and polycystic ovary syndrome: a
response and an alternative view. Epilepsia. 2001 Mar;42(3):305-10. Review.
PubMed PMID: 11442144.
6: Soares JC. Valproate treatment and the risk of hyperandrogenism and polycystic
ovaries. Bipolar Disord. 2000 Mar;2(1):37-41. PubMed PMID: 11254018.
Copyright © 2017, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other lay persons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.